19th Mar 2015 14:26
RNS Number : 9414H
GlaxoSmithKline PLC
19 March 2015
GlaxoSmithKline plc (the "Company")
Director Declaration
In conformity with Listing Rule 9.6.14, the Company hereby notifies the market that Dr Daniel Podolsky, a Non-Executive Director of the Company, has been appointed as a Director to the Board of Agilent Technologies Inc. with effect from 21 July 2015.
V A Whyte
Company Secretary
19 March 2015
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Glaxosmithkline